Drug Chatter -- Tracking biopharma stock chatter

💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch

Profile for Immunomedics, Inc. (IMMU)

« Back to company index

IMMU Chatter Timeline

Stock Ticker for IMMU

Most Active Tweeters for IMMU

@biotechradar_eu 1
@Redeye_ 1
@ResearchPool 1

Recent Tweets for IMMU

ResearchPool @ResearchPool
$IMMU #Immunicum AB Immunicum - Positive interim data for DCP-001: Immunicum has reported positive interim data fro… https://t.co/y1RNUzkxqK
May 17th 2022, 10:05pm
Redeye_ @Redeye_
Redeye comments on Immunicum communicating interim data from its ADVANCE II trial: $IMMU https://t.co/TtKbU7I9A1 https://t.co/1P5DmPdsCj
May 17th 2022, 7:05am
biotechradar_eu @biotechradar_eu
Immunicum $IMMU Announces Positive Interim Results from ADVANCE II Study in AML Maintenance Treatment https://t.co/JXLYJPVJys
May 16th 2022, 6:05am
ResearchPool @ResearchPool
$IMMU #Immunicum AB Immunicum - Catalysts approaching for DCP-001: Immunicum specialises in the research and develo… https://t.co/RBSC0m9LG9
May 11th 2022, 10:05pm
AnalyserNU @AnalyserNU
Analys - Immunicum Catalysts approaching for DCP-001 https://t.co/bn7zdLxxb3 $IMMU #aktieanalys
May 11th 2022, 10:05am
Redeye_ @Redeye_
Immunicum's Q1'22 report came in without any major surprises. Our analyst gives a comment: $IMMU… https://t.co/p4zIxhfDmt
May 10th 2022, 11:05am
biotechradar_eu @biotechradar_eu
Immunicum $IMMU Interim Report January – March 2022 https://t.co/PNTgQuNxYA
May 10th 2022, 8:05am
biotechradar_eu @biotechradar_eu
Immunicum $IMMU Appoints Leopold Bertea as Chief Technology Officer https://t.co/spmwTkb7pI
May 5th 2022, 6:05am
biotechradar_eu @biotechradar_eu
Immunicum $IMMU to Present Preclinical Data Demonstrating Synergy of DCP-001 with Standard Treatments for Acute Mye… https://t.co/pfdFQiToqU
May 3rd 2022, 2:05pm
andrewross11 @andrewross11
$gild long 900 @ 59.65; now that $immu impairment has been put to sleep; earnings going forward should be stellar;… https://t.co/z47zYu3FNj
April 29th 2022, 7:04pm
newsfilterio @newsfilterio
Gilead first quarter sales, earnings beat Street estimates $IMMU https://t.co/SmhjI0USLA
April 29th 2022, 12:04am
newsfilterio @newsfilterio
Gilead earnings beat Street estimates, writedown taken on cancer drug $IMMU https://t.co/dqu5ZObgOD
April 29th 2022, 12:04am
BiotechObserver @BiotechObserver
@bradloncar Hey, at least they got some accounting benefits from $IMMU acquisition lol
April 28th 2022, 10:04pm
biotechradar_eu @biotechradar_eu
Immunicum $IMMU Immunicum Publishes Phase II MERECA Trial Results of Ilixadencel in Kidney Cancer in European Urolo… https://t.co/1NPETU6aky
April 28th 2022, 7:04am
Hall8Jack @Hall8Jack
RT @BertrandBio: US biotech news flow this morning: $TGTX BLA withdrawal from this weekend, a settlement of class action from former $IMMU,…
April 18th 2022, 4:04pm
bradloncar @bradloncar
@ZacharyBrennan Back then $IMMU felt like one of those shady biotech companies that wasn't serious. Definitely an i… https://t.co/qKi2XvOtho
April 18th 2022, 12:04pm
gcasher @gcasher
@equitydotguru 20 years; ended in a buyout; $IMMU
April 14th 2022, 12:04pm
PaulTorresCohen @PaulTorresCohen
Paul Torres-Cohen $IMMU
April 13th 2022, 4:04am
kingkappital @kingkappital
$IMMU was at 9 .. 6 months before the buyout. "double downgraded" day before the life changing data released,… https://t.co/Q559Cn5CEu
April 10th 2022, 9:04pm
GripRoom @GripRoom
The manipulation on $RAD today is pretty nuts. Might turn into one of those $IMMU type downgrades.
April 7th 2022, 7:04pm
stevedoc22 @stevedoc22
@Sports_bios $GILD is taking a write down of $IMMU deal, they are reportedly firing > 100 employees and their "top… https://t.co/c479vPfGPI
March 10th 2022, 12:03pm
DuaneReadeSanta @DuaneReadeSanta
What would $IMMU's market cap be as a public company today?
March 7th 2022, 3:03pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.